Showing results (161-170 of 203) with videos related to

Sort By:
Pageof 21
JAMA Network Open|May 23, 2024
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized TrialsLeigh H Fisher, Jia Jin Kee, Albert Liu, et al.
Science Translational Medicine|April 17, 2024
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathologyHoang Van Phan, Alexandra Tsitsiklis, Cole P Maguire, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2021
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cellsKristen W Cohen, Susanne L Linderman, Zoe Moodie, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Rapid generation of neutralizing antibody responses in COVID-19 patientsMehul S Suthar, Matthew Zimmerman, Robert Kauffman, et al.
Cell Reports. Medicine|July 12, 2021
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cellsKristen W Cohen, Susanne L Linderman, Zoe Moodie, et al.
Science (New York, N.Y.)|August 14, 2020
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humansPrabhu S Arunachalam, Florian Wimmers, Chris Ka Pun Mok, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variantVenkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 26, 2023
Persistent SARS-CoV-2-specific immune defects in kidney transplant recipients following third mRNA vaccine doseWilliam A Werbel, Andrew H Karaba, Teresa Po-Yu Chiang, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2022
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein VaccineGustavo H Dayan, Nadine Rouphael, Stephen R Walsh, et al.
Eclinicalmedicine|November 8, 2023
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country studyGustavo H Dayan, Nadine Rouphael, Stephen R Walsh, et al.
Pageof 21